BACKGROUND AND PURPOSE: Magnetization transfer ratio (MTR) histogram analysis and volumetric MR imaging are sensitive tools with which to quantify the tissue destructive effects in patients with white matter or neurodegenerative disease. Our purpose was to determine whether whole brain MTR and fractional brain parenchyma volume measurements are altered in HIV-1-infected patients who are neurologically symptomatic and in those who are asymptomatic. METHODS: We performed MR imaging and MTR studies of 15 neurologically symptomatic (seven patients) and asymptomatic (eight patients) HIV-1-seropositive patients and compared their findings with those of 10 seronegative normal control participants. MTR was computed on the basis of whole brain parenchyma segmented by using thin section dual echo MR images. RESULTS: The loss of brain tissue, indicated by fractional brain parenchyma volume, was more pronounced in neurologically symptomatic patients (P =.003) but not in asymptomatic patients (P =.23) when compared with control participants. As for whole brain MTR histogram analysis, both patient groups showed significant decrease in mean (P =.02) and median (P < or =.009) values, compared with normal control participants. There was a trend toward positive correlation (r > or = 0.56) between MTR histogram statistics and fractional brain parenchyma volume. CONCLUSION: Our results suggest that MTR histogram analysis is sensitive in detecting early involvement in neurologically asymptomatic patients with HIV and may, therefore, be used as a combined tool with volumetric measurement, which showed significant tissue loss only in symptomatic patients, to assess various stages of brain damage induced by HIV.
BACKGROUND AND PURPOSE: Magnetization transfer ratio (MTR) histogram analysis and volumetric MR imaging are sensitive tools with which to quantify the tissue destructive effects in patients with white matter or neurodegenerative disease. Our purpose was to determine whether whole brain MTR and fractional brain parenchyma volume measurements are altered in HIV-1-infectedpatients who are neurologically symptomatic and in those who are asymptomatic. METHODS: We performed MR imaging and MTR studies of 15 neurologically symptomatic (seven patients) and asymptomatic (eight patients) HIV-1-seropositivepatients and compared their findings with those of 10 seronegative normal control participants. MTR was computed on the basis of whole brain parenchyma segmented by using thin section dual echo MR images. RESULTS: The loss of brain tissue, indicated by fractional brain parenchyma volume, was more pronounced in neurologically symptomatic patients (P =.003) but not in asymptomatic patients (P =.23) when compared with control participants. As for whole brain MTR histogram analysis, both patient groups showed significant decrease in mean (P =.02) and median (P < or =.009) values, compared with normal control participants. There was a trend toward positive correlation (r > or = 0.56) between MTR histogram statistics and fractional brain parenchyma volume. CONCLUSION: Our results suggest that MTR histogram analysis is sensitive in detecting early involvement in neurologically asymptomatic patients with HIV and may, therefore, be used as a combined tool with volumetric measurement, which showed significant tissue loss only in symptomatic patients, to assess various stages of brain damage induced by HIV.
Authors: M A van Buchem; J K Udupa; J C McGowan; Y Miki; F H Heyning; M P Boncoeur-Martel; D L Kolson; M Polansky; R I Grossman Journal: AJNR Am J Neuroradiol Date: 1997-08 Impact factor: 3.825
Authors: J C Stout; R J Ellis; T L Jernigan; S L Archibald; I Abramson; T Wolfson; J A McCutchan; M R Wallace; J H Atkinson; I Grant Journal: Arch Neurol Date: 1998-02
Authors: V Dousset; R I Grossman; K N Ramer; M D Schnall; L H Young; F Gonzalez-Scarano; E Lavi; J A Cohen Journal: Radiology Date: 1992-02 Impact factor: 11.105
Authors: E H Aylward; J D Henderer; J C McArthur; P D Brettschneider; G J Harris; P E Barta; G D Pearlson Journal: Neurology Date: 1993-10 Impact factor: 9.910
Authors: E H Aylward; P D Brettschneider; J C McArthur; G J Harris; T E Schlaepfer; J D Henderer; P E Barta; A Y Tien; G D Pearlson Journal: Am J Psychiatry Date: 1995-07 Impact factor: 18.112
Authors: Lisa Singer; Lisa J Wilmes; Emine U Saritas; Ajit Shankaranarayanan; Evelyn Proctor; Dorota J Wisner; Belinda Chang; Bonnie N Joe; Dwight G Nishimura; Nola M Hylton Journal: Acad Radiol Date: 2011-12-22 Impact factor: 3.173
Authors: Hongyan Du; Ying Wu; Renee Ochs; Robert R Edelman; Leon G Epstein; Justin McArthur; Ann B Ragin Journal: Psychiatry Res Date: 2012-08-12 Impact factor: 3.222
Authors: Y Wu; P Storey; A Carrillo; C Saglamer; B A Cohen; L G Epstein; R R Edelman; A B Ragin Journal: AJNR Am J Neuroradiol Date: 2007-10-10 Impact factor: 3.825